Jarun Pharmaceuticals
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.mg)
Hmet Trio 2 Tablet SR is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Hmet Trio 2 Tablet SR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Hmet Trio 2 Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Hmet Trio 2 Tablet SR.
Hmet Trio 2 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Hmet Trio 2 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Hmet Trio 2 Tablet SR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Hmet Trio 2 Tablet SR contains a combination of three medications: Glimepiride, Metformin, and Voglibose. This medicine is prescribed for the treatment of type 2 diabetes mellitus (DM). It helps regulate blood glucose levels in adults when combined with dietary adjustments and regular physical activity. Glimepiride lowers blood sugar by stimulating insulin release from the pancreas. Metformin works by reducing glucose production in the liver and enhancing insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that inhibits postprandial (after meals) glucose level increase in the body. This combination is not indicated for type 1 diabetes treatment.
Common side effects associated with Hmet Trio 2 Tablet SR include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste perception, flatulence, stomach pain, headache, skin rash, and respiratory tract infections. It is important to note that experiencing any of these side effects does not necessarily indicate a serious problem but it's crucial to consult your doctor if you notice any unexpected or prolonged symptoms.
Patients with known allergies to any of the components or excipients of this medicine should refrain from using it. Patients with moderate to severe kidney disease and inflammatory bowel diseases, colonic ulcerations, or underlying metabolic acidosis including diabetic ketoacidosis must avoid this medication as well. If you are experiencing any of these conditions, always consult your doctor before taking this medicine.
No, consuming alcohol alongside Hmet Trio 2 Tablet SR is not advised. It can lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, Hmet Trio 2 Tablet SR can lead to hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, a rapid heart rate, and feeling anxious or shaky. It is more likely to occur if you miss meals, drink alcohol, over-exercise, or take other medications for diabetes along with it. Regular monitoring of blood glucose levels is crucial to address any potential hypoglycemia.
Store this medicine in its original package or container, tightly sealed. Follow the instructions on the medication label. Dispose of unused medication appropriately, ensuring it is inaccessible to pets, children, and other individuals.